Suppr超能文献

整合 mRNAseq 和 microRNAseq 数据分析用于 III 级神经胶质瘤。

Integrated mRNAseq and microRNAseq data analysis for grade III gliomas.

机构信息

Department of Neurosurgery, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, P.R. China.

Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, P.R. China.

出版信息

Mol Med Rep. 2017 Nov;16(5):7468-7478. doi: 10.3892/mmr.2017.7545. Epub 2017 Sep 20.

Abstract

The World Health Organization classification distinguishes four grades for gliomas. Grade III gliomas, which are brain malignant brain tumors with variable biological behavior and propensity, have been not widely investigated. The objective of the present study was to identify specific gene modules and valuable hubs associated with gliomagenesis and molecular signatures to assist in determining grade III glioma prognosis. mRNAseq and micro (mi)RNAseq data were used to construct a co‑expression network of gliomas using weight gene co‑expression network analysis, and revealed the prognostic molecular signature of grade III gliomas. The differently expressed miRNAs and mRNAs were identified. A total of 37 mRNAs and 10 miRNAs were identified, which were closely associated with the survival rates of patients with grade III glioma. To further understand the tumorigenesis, Cytoscape software was used to construct a network containing these differently expressed molecules. The result suggested that both the downregulated genes and upregulated genes are vital in the process of glioma deterioration, and certain genes are closely associated with clinical prognosis.

摘要

世界卫生组织(WHO)分类将神经胶质瘤分为四级。III 级神经胶质瘤是一种具有不同生物学行为和倾向的恶性脑肿瘤,但尚未得到广泛研究。本研究旨在确定与神经胶质瘤发生和分子特征相关的特定基因模块和有价值的枢纽,以协助确定 III 级神经胶质瘤的预后。使用加权基因共表达网络分析(WGCNA)对神经胶质瘤进行 mRNAseq 和 micro(mi)RNAseq 数据构建共表达网络,揭示 III 级神经胶质瘤的预后分子特征。鉴定出差异表达的 miRNAs 和 mRNAs。共鉴定出 37 个 mRNAs 和 10 个 miRNAs,这些 mRNAs 和 miRNAs 与 III 级神经胶质瘤患者的生存率密切相关。为了进一步了解肿瘤发生机制,使用 Cytoscape 软件构建了包含这些差异表达分子的网络。结果表明,下调基因和上调基因在胶质瘤恶化过程中都很重要,某些基因与临床预后密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/5865882/debfa8d44c8d/mmr-16-05-7468-g02.jpg

相似文献

1
Integrated mRNAseq and microRNAseq data analysis for grade III gliomas.
Mol Med Rep. 2017 Nov;16(5):7468-7478. doi: 10.3892/mmr.2017.7545. Epub 2017 Sep 20.
2
Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
Oncol Rep. 2015 Jul;34(1):318-24. doi: 10.3892/or.2015.3953. Epub 2015 May 6.
3
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Tumour Biol. 2016 Oct;37(10):14035-14048. doi: 10.1007/s13277-016-5273-x. Epub 2016 Aug 6.
4
An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
Tumour Biol. 2016 Jun;37(6):7185-92. doi: 10.1007/s13277-015-4585-6. Epub 2015 Dec 14.
6
Molecular profiles for insular low-grade gliomas with putamen involvement.
J Neurooncol. 2018 Jul;138(3):659-666. doi: 10.1007/s11060-018-2837-1. Epub 2018 Mar 19.
7
Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
J Neurooncol. 2016 Mar;127(1):23-32. doi: 10.1007/s11060-015-2017-5. Epub 2015 Dec 8.
8
Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
J Neurooncol. 2016 Apr;127(2):235-42. doi: 10.1007/s11060-015-2040-6. Epub 2016 Jan 2.

引用本文的文献

2
Inferring Diagnostic and Prognostic Gene Expression Signatures Across WHO Glioma Classifications: A Network-Based Approach.
Bioinform Biol Insights. 2024 Sep 15;18:11779322241271535. doi: 10.1177/11779322241271535. eCollection 2024.
3
High Expression of KIFC1 in Glioma Correlates with Poor Prognosis.
J Korean Neurosurg Soc. 2024 May;67(3):364-375. doi: 10.3340/jkns.2023.0155. Epub 2024 May 1.
4
An approach to the identification of diagnostic and prognostic markers in low-grade gliomas.
PeerJ. 2023 Mar 16;11:e15096. doi: 10.7717/peerj.15096. eCollection 2023.
5
An integrated multi-omics analysis of topoisomerase family in pan-cancer: Friend or foe?
PLoS One. 2022 Oct 26;17(10):e0274546. doi: 10.1371/journal.pone.0274546. eCollection 2022.
6
Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis.
Biomed Res Int. 2021 May 19;2021:5587441. doi: 10.1155/2021/5587441. eCollection 2021.
8
Investigation of miRNA and mRNA Co-expression Network in Ependymoma.
Front Bioeng Biotechnol. 2020 Mar 19;8:177. doi: 10.3389/fbioe.2020.00177. eCollection 2020.
9
Tumor Suppressor microRNA-138 Suppresses Low-Grade Glioma Development and Metastasis via Regulating IGF2BP2.
Onco Targets Ther. 2020 Mar 13;13:2247-2260. doi: 10.2147/OTT.S232795. eCollection 2020.

本文引用的文献

1
KIFC1: a promising chemotherapy target for cancer treatment?
Oncotarget. 2016 Jul 26;7(30):48656-48670. doi: 10.18632/oncotarget.8799.
3
Overexpression of tissue microRNA10b may help predict glioma prognosis.
J Clin Neurosci. 2016 Jul;29:59-63. doi: 10.1016/j.jocn.2015.10.046. Epub 2016 Mar 14.
4
miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE.
Oncol Lett. 2016 Jan;11(1):904-908. doi: 10.3892/ol.2015.3927. Epub 2015 Nov 17.
6
Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
Oncotarget. 2016 Jan 26;7(4):4746-59. doi: 10.18632/oncotarget.6621.
7
Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.
Tumour Biol. 2016 Feb;37(2):2193-207. doi: 10.1007/s13277-015-3938-5. Epub 2015 Sep 9.
8
Prognostic significance of multiple kallikreins in high-grade astrocytoma.
BMC Cancer. 2015 Aug 1;15:565. doi: 10.1186/s12885-015-1566-5.
10
A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
PLoS One. 2014 Oct 3;9(10):e108950. doi: 10.1371/journal.pone.0108950. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验